Biomarker Panel for Chronic Graft-Versus-Host Disease. - Wikidata - wikimedia - TriplyDB

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Biomarker Panel for Chronic Graft-Versus-Host Disease.

http://www.wikidata.org/entity/Q37234820

about

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.Editorial: Danger Signals Triggering Immune Response and Inflammation.Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Biomarkers in chronic graft-versus-host disease: quo vadis?Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.Changes in protein serum levels during stem cell transplantation.Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.Biomarkers for post-transplantation outcomes.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

P2860

Q33593742-5DD73BA7-ED61-44D8-97EE-193855F6F0E6 Q33798102-2CB6A118-B6A3-4243-A7F1-0F236F3405AA Q33809599-34100D0D-4797-4C02-A8DD-DA8EB98B6F39 Q37522548-6867B08A-8918-46C7-B656-F335C2E1D7B6 Q37585022-C84D4D73-8A3E-4D4C-9FD5-3CF2EBFD8CE3 Q37587724-C6AA9B16-0BE7-4A12-91E5-A9A00DEA455F Q38798545-8FDB821B-A346-484C-B586-7CABF6545357 Q42345013-8F4032EC-4CC6-45F6-A88D-D3909E3DB4EB Q42737499-F1380F8B-6651-48A1-B8A2-04374C33F897 Q47312420-E30109E9-1EE1-471A-AE5E-F2DF9120269A Q47713449-E8809893-8079-4C1D-B508-5F28ECB2B2BD Q47743495-1D259443-E986-4C6F-B53C-E7A2DA46DDAF Q47969259-E106493B-9C45-4F02-9FC5-14CA625F8995 Q49464975-199E4613-49FF-4939-89D3-6D572488E85D Q49645938-D7A67122-6BBA-49D2-A4FC-4FDEBEC9AC9E Q49954477-E1DF03B1-A211-4148-90B6-E723509269D4 Q51028682-4667AB65-AF77-482F-811E-F3A859021005 Q51455474-E4497180-42C5-4646-944F-9F67CDF11428 Q52603913-298897B2-8AB9-4C96-A4D7-65C3C3D5F51E Q55045366-A6FB381B-FC9C-4149-817C-8793790393F4 Q55375763-DB3AAD90-A019-40EF-B831-5554BB8C111E Q58782275-B324E130-9BF1-4067-8D77-920B8BDF3F24

P2860

Biomarker Panel for Chronic Graft-Versus-Host Disease.

http://www.wikidata.org/entity/Q37234820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@en

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@nl

type

label

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@en

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@nl

prefLabel

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@en

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@nl

P1433

Q37234820-CF725FC4-A117-410C-BB41-A621D1EF01DA

P1476

Q37234820-97E6BC03-C865-4916-8B90-6813F2616A1B

P2093

Q37234820-036FA761-3C85-4448-A37A-F827E312445E

Q37234820-0DADD3C9-F910-41A2-96D7-FEAD8BF44F3A

Q37234820-0E1A47F2-909C-4400-88B0-817D7DF87546

Q37234820-14C83071-C669-4AE6-9E15-EB27DA686C33

Q37234820-2D973D30-99D2-4126-9F18-7CC0D618103A

Q37234820-46052CAB-E98A-4068-B179-ACEC6C50C786

Q37234820-7589F495-36A6-4A5F-AED1-F5B35A108056

Q37234820-920C7D98-50EB-46C4-BD62-08EB99243AE3

Q37234820-9AA4EB92-4357-4192-9A87-8EAE72D463FF

Q37234820-9F8F831C-C470-4F4D-AD0A-38681DE36D4E

P2860

Q37234820-2D40A8DD-25C4-4A5A-A7AF-99F6696825CC

Q37234820-37932366-EAFB-424B-BBED-B8A29260F639

Q37234820-44BAD759-AED0-40E3-9A79-5B47A82D2242

Q37234820-49B9CA9B-0917-4611-90F3-87306F001F98

Q37234820-60249FDA-5D57-44C7-9E60-8F9EB8E246B2

Q37234820-638FE600-1DD8-4213-950E-8DBD1A955A9D

Q37234820-7AAC4C10-71DE-4E97-B3DE-CEC0E1FE6682

Q37234820-888BAA0D-375B-4C31-8185-A592CD53F7BC

Q37234820-8FA6626C-6E70-4F17-9FC4-61336881B7F9

Q37234820-9C72C573-6DD8-4D4C-9388-C80D469A8456

P304

Q37234820-CD70DB65-FC5B-4BD9-9B32-2B30D477BDDB

P31

Q37234820-3AD52708-B8DB-4272-8480-1139D1D66D37

P356

Q37234820-2E8DBFBB-386A-4E35-9335-357DDF9DBFDC

P407

Q37234820-16BC5E1A-9ECC-496B-9110-EC7313291C09

P433

Q37234820-24B36AEB-0670-4577-B3D3-5696A8F0FDE1

P478

Q37234820-F3541BAA-0D77-4E23-96BC-07EA7A7CBEE8

P50

Q37234820-70FE3D86-BAE5-47DE-BA11-F2D8B9E8FC76

Q37234820-BF9ECFD2-26E1-47C1-8FE8-4702B8A66411

P577

Q37234820-F9F559B4-43E1-41B5-B126-E6E8C0483A65

P698

Q37234820-18C04929-7FBC-445D-8932-1CAF0703A626

P921

Q37234820-3C140D35-FF99-4248-B9AF-2C36BCF039CB

P932

Q37234820-501F403F-B298-4360-A18F-1193C11B9364

P356

JCO.2015.65.9615

P1433

Journal of Clinical Oncology

P1476

Biomarker Panel for Chronic Graft-Versus-Host Disease.

@en

P2093

Betty K Hamilton

http://www.w3.org/2001/XMLSchema#string

Corey Cutler

http://www.w3.org/2001/XMLSchema#string

George L Chen

http://www.w3.org/2001/XMLSchema#string

Iskra Pusic

http://www.w3.org/2001/XMLSchema#string

Jeffrey Yu

http://www.w3.org/2001/XMLSchema#string

John A Hansen

http://www.w3.org/2001/XMLSchema#string

Joseph Pidala

http://www.w3.org/2001/XMLSchema#string

Kushi Kushekhar

http://www.w3.org/2001/XMLSchema#string

Madan Jagasia

http://www.w3.org/2001/XMLSchema#string

Mary E Flowers

http://www.w3.org/2001/XMLSchema#string

P2860

Elafin is a biomarker of graft-versus-host disease of the skin

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

Matrix metalloproteinases and the regulation of tissue remodelling

Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

P304

2583-2590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.65.9615

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Paczesny

P577

2016-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217465

http://www.w3.org/2001/XMLSchema#string

P921

P932

5012688

http://www.w3.org/2001/XMLSchema#string